DAWN YONKEE: Open Payments
NPI 1912217464 · PLANT CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,591 in 86 payments from 15 companies in 2025. Trend: 2023 $1,586 · 2024 $1,922 · 2025 $1,591
Food & beverage: $1,591
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $390 |
| PFIZER INC. | 17 | $231 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $222 |
| Lilly USA, LLC | 8 | $150 |
| AstraZeneca Pharmaceuticals LP | 7 | $144 |
| ABBVIE INC. | 5 | $105 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $78 |
| Amgen Inc. | 5 | $73 |
| GlaxoSmithKline, LLC. | 2 | $47 |
| Exact Sciences Corporation | 3 | $46 |
Products named: JARDIANCE, Ozempic, Wegovy, AIRSUPRA, NURTEC ODT, VRAYLAR, Kerendia, ELIQUIS.
Industry payments across FL — which companies pay providers there.
